|
2024 Journal Article Assessing the effect of Riluzole on motor unit discharge propertiesShandiz, Ehsan, Fernandes, Gabriel Lima, Henkin, Joao Saldanha, McCombe, Pamela Ann, Trajano, Gabriel Siqueira and Henderson, Robert David (2024). Assessing the effect of Riluzole on motor unit discharge properties. Brain Sciences, 14 (11) 1053, 1053. doi: 10.3390/brainsci14111053 |
|
2024 Journal Article Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymesTupil, Ajay R., Rivlin, Warwick, Mccombe, Pamela A., Henderson, Robert D., Rodgers, Jonathan and Vadlamudi, Lata (2024). Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymes. Neurology Genetics, 10 (6) e200205, e200205. doi: 10.1212/nxg.0000000000200205 |
|
2024 Conference Publication Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaborationLaing, N., Kennerson, M., Lamont, P., Vucic, S., Davis, M., Bryson-Richardson, R., Ravenscroft, G., Perez-Siles, G., Ghaoui, R., Narayanan, R., McCombe, P., Deveson, I., Bryen, S., Grosz, B., Johari, M., Rick, A., Folland, C., Scriba, C., Parmar, J. and Ellis, M. (2024). Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaboration. 29th International Congress of the World-Muscle-Society (WMS), Prague, Czech Republic, 8-12 October 2024. London, United Kingdom: Elsevier. doi: 10.1016/j.nmd.2024.07.328 |
|
2024 Journal Article Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre studySiriratnam, Pakeeran, Sanfilippo, Paul, van der Walt, Anneke, Sharmin, Sifat, Foong, Yi Chao, Yeh, Wei Zhen, Zhu, Chao, Khoury, Samia Joseph, Csepany, Tunde, Willekens, Barbara, Etemadifar, Masoud, Ozakbas,, Serkan, Nytrova, Petra, Altintas, Ayse, Al-Asmi, Abdullah, Yamout, Bassem, Laureys, Guy, Patti, Francesco, Simo, Magdolna, Surcinelli, Andrea, Foschi, Matteo, McCombe, Pamela A, Alroughani, Raed, Sánchez-Menoyo, José Luis, Turkoglu, Recai, Soysal, Aysun, Lechner Scott, Jeanette, Kalincik, Tomas, Butzkueven, Helmut ... Monif, Mastura (2024). Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study. Journal of Neurology, Neurosurgery and Psychiatry, 96 (4) jnnp-2024-334090, 1-9. doi: 10.1136/jnnp-2024-334090 |
|
2024 Conference Publication Clinically silent MRI lesions are associated with subsequent relapses and disability worsening in treated people with RRMSDaruwalla, Cyrus, Kremler, Courtney, Adesoye, Gbenga, Patti, Francesco, Ozakbas, Serkan, Boz, Cavit, Lechner-Scott, Jeannette, Yamout, Bassem I., Khoury, Samia, van der Walt, Anneke, Butzkueven, Helmut, Foschi, Matteo, Surcinelli, Andrea, Alroughani, Raed, Spitaleri, Daniele L. a., Ayuso, Guillermo Izquierdo, Madueno, Sara Eichau, Buzzard, Katherine, Skibina, Olga, Grammond, Pierre, Blanco, Yolanda, Laureys, Guy, Van Hijfte, Liesbeth, Sanchez, Jose Luis, Maimone, Davide, Mccombe, Pamela, Van Pesch, Vincent, Oh, Jiwon, Gray, Orla ... Brown, J. William L. (2024). Clinically silent MRI lesions are associated with subsequent relapses and disability worsening in treated people with RRMS. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Conference Publication Effectiveness of autologous haematopoietic stem cell transplantation in comparison with immune-reconstitution therapies in relapsing-remitting MSKalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Oivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, William, Coles, Alasdair, Van der Walt, Anneke, Butzkueven, Helmut, Van Wijmeersch, Bart, Lechner-Scott, Jeannette, Barnett, Michael, Laureys, Guy, Van Hijfte, Liesbeth, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga ... Snowden, John (2024). Effectiveness of autologous haematopoietic stem cell transplantation in comparison with immune-reconstitution therapies in relapsing-remitting MS. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Conference Publication Driving forces: Investigating Menopause's Influence on MS Disability ProgressionBridge, Francesca, Sanfilippo, Paul, Skibina, Olga, Nguyen, Ai-Lan, Kalincik, Tomas, Buzzard, Katherine, Taylor, Bruce, MacIntyre, Jennifer, Hall, Lesley-Ann, Slee, Mark, Macdonell, Richard, Maltby, Vicki, Lechner-Scott, Jeannette, McCombe, Pamela, Butzkueven, Helmut, van der Walt, Anneke and Jokubaitis, Vilija (2024). Driving forces: Investigating Menopause's Influence on MS Disability Progression. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Conference Publication Real-world experience with Cladribine (Mavenclad) in the MSBase registryButzkueven, Helmut, Spelman, Tim, Van der Walt, Anneke, Hodgkinson, Suzanne, Ozakbas, Serkan, Alroughani, Raed, Kalincik, Tomas, Eichau, Sara, Boz, Cavit, Buzzard, Katherine, Habek, Mario, John, Nevin, Kermode, Allan G., Foschi, Matteo, McCombe, Pamela, Gerlach, Oliver, Prevost, Julie, Meca-Lallana, Jose E., Lapointe, Emmanuelle and Jarvinen, Elina (2024). Real-world experience with Cladribine (Mavenclad) in the MSBase registry. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Preserving neurological function in patients at high risk and low risk of aggressive MSRoos, Izanne, Sharmin, Sifat, Ozakbas, Serkan, Alroughani, Raed, Ayuso, Guillermo Izquierdo, Madueno, Sara Eichau, Grand'Maison, Francois, Boz, Cavit, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Yamout, Bassem I., Khoury, Samia, Grammond, Pierre, van der Walt, Anneke, Butzkueven, Helmut, Blanco, Yolanda, Foschi, Matteo, Surcinelli, Andrea, Soysal, Aysun, Barnett, Michael, Prevost, Julie, Terzi, Murat, Gerlach, O., Macdonell, Richard, Sa, Maria Jose ... Kalincik, Tomas (2024). Preserving neurological function in patients at high risk and low risk of aggressive MS. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Conference Publication Individualised prediction of on-treatment relapse using pretreatment clinical data: an MSBase machine learning studyKremler, Courtney, Imrie, Fergus, Barnett, Michael, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Buzzard, Katherine, Garber, Justin, Slee, Mark, Mccombe, Pamela, van der Walt, Anneke, Macdonell, Richard, Van Pesch, Vincent, Laureys, Guy, Willekens, Barbara, Prevost, Julie, Duquette, Pierre, Grammond, Pierre, Grand'Maison, Francois, Ampapa, Radek, Castillo-Trivino, Tamara, Eichau, Sara, Luis Sanchez, Jose, Tello, Cristinaramo, Blanco, Yolanda, Besora, Sarah, Gray, Orla, Cartechini, Elisabetta, Amato, Maria Pia, Spitaleri, Daniele L. A. ... Brown, J. William L. (2024). Individualised prediction of on-treatment relapse using pretreatment clinical data: an MSBase machine learning study. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Conference Publication Practical Clinical Predictions: MSBase Validation of the DAAE Score, A Clinical Tool for Estimating Risk of Conversion to Secondary Progressive Multiple SclerosisFuchs, Tom, Schoonheim, Menno, Uher, Tomas, Horakova, Dana, Havrdova, Eva Kubala, Jelgerhuis, Julia, Grammond, Pierre, Khoury, Samia, Sa, Maria Jose, Lorscheider, Johannes, Cartechini, Elisabetta, Maimone, Davide, Oreja-Guevara, Celia, D'hooghe, Marie, Fabis-Pedrini, Marzena, Oh, Jiwon, Lalive, Patrice, Willekens, Barbara, Ozakbas, Serkan, Eichau, Sara, Girard, Marc, Duquette, Pierre, Patti, Francesco, Alroughani, Raed, Lugaresi, Alessandra, Tomassini, Valentina, Terzi, Murat, Amato, Maria Pia, Kalincik, Tomas ... Weinstock-Guttman, Bianca (2024). Practical Clinical Predictions: MSBase Validation of the DAAE Score, A Clinical Tool for Estimating Risk of Conversion to Secondary Progressive Multiple Sclerosis. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Conference Publication A standardised definition of progression independent of relapse activity in multiple sclerosisMueller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Ozakbas, Serkan, Karabudak, Rana, Horakova, Dana, Weinstock-Guttman, Bianca, Shaygannejad, Vahid, Etemadifar, Masoud, Boz, Cavit, Alroughani, Raed, Patti, Francesco, Izquierdo Ayuso, Guillermo, Eichau Madueno, Sara, Prat, Alexandre, Terzi, Murat, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan, Carroll, William, Grand'Maison, Francois, Amato, Maria Pia, Grammond, Pierre, Sajedi, Aidin, Turkoglu, Recai, Altintas, Ayse, Buzzard, Katherine, Skibina, Olga, Soysal, Aysun ... Kalincik, Tomas (2024). A standardised definition of progression independent of relapse activity in multiple sclerosis. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Conference Publication Real-world Australian experience with Ofatumumab in the MSBase RegistryBarnett, Michael, van der Walt, Anneke, Butzkueven, Helmut, Kalincik, Tomas, Spelman, Tim, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William M., Lechner-Scott, Jeannette, John, Nevin, Hodgkinson, Suzanne, McCombe, Pamela, Macdonell, Richard, Slee, Mark, Migocki, Margaret, Martel, Kate and Schmitt, Birte (2024). Real-world Australian experience with Ofatumumab in the MSBase Registry. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Change in serum NfL over time is associated with response to treatment in people with MS taking cladribineMaltby, Vicki, Lea, Rodney, Xavier, Alexandre, Monif, Mastura, Min, Myintzu, Pedrini, Marzena, Buzzard, Katherine, Kalincik, Tomas, Kermode, Allan, Taylor, Bruce, Hodgkinson, Suzanne, Mccombe, Pamela, Osborne, Meaghan, Butzkueven, Helmut, Barnett, Michael, Leppert, David, Kuhle, Jens and Lechner-Scott, Jeannette (2024). Change in serum NfL over time is associated with response to treatment in people with MS taking cladribine. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD. |
|
2024 Journal Article Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patientsJiang, Leanne, Tracey, Timothy J., Gill, Melinder K., Howe, Stephanie L., Power, Dominique T., Bharti, Vanda, McCombe, Pamela A., Henderson, Robert D., Steyn, Frederik J. and Ngo, Shyuan T. (2024). Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients. Stem Cell Research, 78 103447, 1-6. doi: 10.1016/j.scr.2024.103447 |
|
2024 Conference Publication Employing Novel Indirect Treatment Comparison Methodologies to Differentiate the Efficacy of Ofatumumab and Other High Efficacy Therapies versus Orally Administered Disease Modifying Therapies for Relapsing Multiple SclerosisNelson, Morag, Butzkueven, Helmut, Van der Walt, Anneke, Broadley, Simon, Riley, Nicholas, Adlard, Nicholas, Merschhemke, Martin, Stoneman, Dee, McCombe, Pamela, Barnett, Michael, Walker, Rob, Samjoo, Imtiaz, Haltner, Anja and Drudge, Chris (2024). Employing Novel Indirect Treatment Comparison Methodologies to Differentiate the Efficacy of Ofatumumab and Other High Efficacy Therapies versus Orally Administered Disease Modifying Therapies for Relapsing Multiple Sclerosis. 16th Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis, Bangkok, Thailand, 30 October - 2 November 2024. London, United Kingdom: Sage Publications. |
|
2024 Journal Article Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosisRoos, Izanne, Sharmin, Sifat, Malpas, Charles, Ozakbas, Serkan, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Alroughani, Raed, Eichau Madueño, Sara, Boz, Cavit, van der Walt, Anneke, Butzkueven, Helmut, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Grand’Maison, Francois, John, Nevin, Grammond, Pierre, Terzi, Murat, Prévost, Julie, Barnett, Michael, Laureys, Guy, Van Hijfte, Liesbeth, Luis Sanchez-Menoyo, Jose, Blanco, Yolanda, Oh, Jiwon, McCombe, Pamela, Ramo Tello, Cristina, Soysal, Aysun, Prat, Alexandre ... Kalincik, Tomas (2024). Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 30 (9), 1163-1175. doi: 10.1177/13524585241267211 |
|
2024 Conference Publication Utilisation of high efficacy therapy for managing multiple sclerosis in AustraliaMcCombe, Pamela, Butzkueven, Helmut, Samjoo, Imtiaz, Barnett, Michael, Broadley, Simon, Walt, Anneke Van der, Merschhemke, Martin, Adlard, Nicholas, Burke, Naomi, Riley, Nicholas and Walker, Rob (2024). Utilisation of high efficacy therapy for managing multiple sclerosis in Australia. ANZAN Annual Scientific Meeting 2024, Adelaide, SA Australia, 21-24 May 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2024-anzan.23 |
|
2024 Conference Publication Real-world Australian experience with Ofatumumab in the MSBase registryMigocki, Margaret, Walt, Anneke Van der, Butzkueven, Helmut, Spelman, Tim, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William M., Lechner-Scott, Jeannette, John, Nevin, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark and Schmitt, Birte (2024). Real-world Australian experience with Ofatumumab in the MSBase registry. ANZAN Annual Scientific Meeting 2024, Adelaide, SA Australia, 21-24 May 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2024-anzan.127 |
|
2024 Journal Article The clinical relevance of MOG antibody testing in cerebrospinal fluidReynolds, Molly, Tan, Irene, Nguyen, Kristy, Merheb, Vera, Lee, Fiona X. Z., Trewin, Benjamin P, Lerch, Magdalena, Shah, Snehal, Wolfe, Nigel, Buzzard, Katherine, Lechner-Scott, Jeannette, Fabis-Pedrini, Marzena, Fok, Anthony, John, Nevin, Kneebone, Chris, Yiannikas, Con, Brown, David A., Kermode, Allan G., Reddel, Stephen, Dale, Russell C., Brilot, Fabienne, Ramanathan, Sudarshini, Adam, Robert, Andersen, Jane, Andrews, Ian, Antony, Jayne, Aouad, Patrick, Badve, Monica, Barnett, Michael H. ... on behalf of the Australasian MOGAD Study Group (2024). The clinical relevance of MOG antibody testing in cerebrospinal fluid. Annals of Clinical and Translational Neurology, 11 (9), 1-6. doi: 10.1002/acn3.52163 |
